Brokers Set Expectations for Spectral AI Q3 Earnings

Spectral AI, Inc. (NASDAQ:MDAI) – Investment analysts at Zacks Small Cap issued their Q3 2025 earnings per share (EPS) estimates for Spectral AI in a report released on Monday, May 19th. Zacks Small Cap analyst J. Vandermosten anticipates that the company will earn ($0.09) per share for the quarter. The consensus estimate for Spectral AI’s current full-year earnings is ($0.48) per share.

Separately, HC Wainwright restated a “buy” rating and issued a $3.50 price objective on shares of Spectral AI in a report on Wednesday, April 2nd.

Spectral AI Stock Up 0.7%

NASDAQ MDAI opened at $1.36 on Wednesday. The firm’s 50 day moving average is $1.31 and its 200-day moving average is $1.69. The company has a market capitalization of $34.43 million, a PE ratio of -2.09 and a beta of 0.59. Spectral AI has a 12-month low of $0.82 and a 12-month high of $3.25.

Spectral AI (NASDAQ:MDAI) last released its earnings results on Thursday, March 27th. The company reported ($0.06) EPS for the quarter, beating the consensus estimate of ($0.13) by $0.07. The firm had revenue of $7.60 million during the quarter, compared to the consensus estimate of $6.83 million.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of MDAI. Millington Financial Advisors LLC bought a new position in Spectral AI during the fourth quarter worth about $85,000. Avantax Planning Partners Inc. lifted its position in shares of Spectral AI by 44.7% in the fourth quarter. Avantax Planning Partners Inc. now owns 231,336 shares of the company’s stock valued at $655,000 after buying an additional 71,484 shares during the last quarter. Virtu Financial LLC acquired a new stake in shares of Spectral AI in the fourth quarter valued at approximately $38,000. Renaissance Technologies LLC acquired a new position in shares of Spectral AI during the 4th quarter worth approximately $272,000. Finally, Northern Trust Corp bought a new stake in Spectral AI in the 4th quarter valued at $44,000. 67.08% of the stock is currently owned by institutional investors and hedge funds.

About Spectral AI

Spectral AI, Inc, an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.